Company: SMNR
Filing Date: 2025-04-21
Form Type: S-4/A
Source: 0001193125-25-087342
Chunk: 705

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-04-21
Form: S-4/A
Chunk 705
---
 reports, proxy statements and other information filed by Denali with the SEC at the SEC’s website at http://www.sec.gov. If you would like additional copies of this proxy statement/prospectus or if you have questions about the Business Combination or the Proposals to be presented at the Meeting, you should contact our proxy solicitor at the following address and telephone number:

<div align='center'>P.O. Box 10904

Yakima, WA 98909

Toll-Free: 877 870-8565

Collect: (206) 870-8565

Email: ksmith@advantageproxy.com</div>

If you are a shareholder of Denali and would like to request documents, please do so by , , in order to receive them before the Meeting. If you request any documents from us, we will mail them to you by first class mail, or another equally prompt means.

Information and statements contained in this proxy statement/prospectus are qualified in all respects by reference to the copy of the relevant contract or other document included as an annex to this proxy statement/prospectus.

All information contained in this proxy statement/prospectus relating to Denali has been supplied by Denali, and all such information relating to Semnur has been supplied by Semnur. Information provided by either the Denali or Semnur does not constitute any representation, estimate or projection of any other party.

Neither Denali nor Semnur has authorized anyone to give any information or make any representation about the Business Combination or their respective companies that is different from, or in addition to, that contained in this proxy statement/prospectus. Therefore, if anyone does give you information of this sort, you should not rely on it. The information contained in this proxy statement/prospectus speaks only as of the date of this proxy statement/prospectus unless the information specifically indicates that another date applies.

<div align='center'>446</div>

TABLE OF CO-REGISTRANTS

| Exact Name ofCo-Registrantas Specified in its Charter(1)(2) |     | State or OtherJurisdiction ofIncorporation orOrganization |          |     | PrimaryStandardIndustrialClassificationCode Number |      |     | I.R.S. EmployerIdentification Number |            |
| Semnur Pharmaceuticals, Inc.                                |     |                                                           | Delaware |     |                                                    | 2836 |     |                                      | 46-2968523 |

(1) The Co-Registranthas the following principal executive office